With its acquisition by Sinocare Group complete, Florida’s Nipro Diagnostics has rebranded as Trividia Health, the company revealed in Fort Lauderdale recently.
“Like Sinocare, Nipro Diagnostics has the long-term vision of being a leading global health and wellness company that offers innovative, high-value solutions so patients can live healthier lives,” Sinocare Chairman and CEO Shaobo Li said. “We have a great deal of respect for what the management team and employees have accomplished at Nipro Diagnostics, and we are confident in their ability to accelerate our shared vision.”
The new Trividia Health Inc., based in Fort Lauderdale as a wholly owned subsidiary of Sinocare Group, develops and distributes advanced products for diabetes patients, partnering with store brands to provide affordable monitoring equipment for pharmacies and other providers.
“Our company has experienced strong growth as a result of our new product launch cadence and our investments in highly sophisticated manufacturing and distribution facilities in the United States,” Scott Verner, Trividia Health CEO, said. “This is an exciting next chapter for our combined company. I’m proud to have led the company through many changes in the public and private markets. I look forward to maximizing the global potential of our portfolio of solutions for patients, health-care providers and our customers.”
2400 N Fort Lauderdale Beach Blvd
Fort Lauderdale, FL 33305